newsfilter
← Latest News
PR Newswire·

Texas Adds Endari® to Latest Preferred Drug List

TORRANCE, Calif., Aug. 2, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC:EMMA), a leader in the treatment of sickle cell disease, announced today that Endari® has been included on the Preferred Drug List published on July 29, 2021, by Texas Healt